0001415889-13-001969.txt : 20131003 0001415889-13-001969.hdr.sgml : 20131003 20131003183552 ACCESSION NUMBER: 0001415889-13-001969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131001 FILED AS OF DATE: 20131003 DATE AS OF CHANGE: 20131003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aasen Thomas H CENTRAL INDEX KEY: 0001291969 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 131135053 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BOULEVARD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 form4-10032013_031043.xml X0306 4 2013-10-01 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001291969 Aasen Thomas H 11085 TORREYANA ROAD #100 SAN DIEGO CA 92121 false true false false EXEC VP, CFO AND CBO Common Stock 2013-10-01 4 M 0 5000 6.95 A 36585 D Common Stock 2013-10-01 4 M 0 17500 1.55 A 54085 D Common Stock 2013-10-01 5 G 0 30000 0 D 24085 D Common Stock 2013-10-01 5 G 0 30000 0 A 30000 I By Family Trust Common Stock 2013-10-01 4 S 0 30000 27.8707 D 0 I By Family Trust Stock Option (right to buy) 6.95 2013-10-01 4 M 0 5000 0 D 2015-03-10 Common Stock 5000 26000 D Stock Option (right to buy) 1.55 2013-10-01 4 M 0 17500 0 D 2020-03-11 Common Stock 17500 123471 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.75 to $28.00 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range. 25% of the shares subject to the Stock Option vested and became exercisable on March 11, 2006. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments. 25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. /s/ Thomas H. Aasen 2013-10-03